Sex Differences in the Efficacy and Safety of Tofacitinib in Patients With Rheumatoid Arthritis: A Post Hoc Analysis of Phase 3 and Long-Term Extension Trials

被引：0
|
作者：
Jones, Niall [1 ]
Strand, Vibeke [2 ]
Schulze-Koops, Hendrik [3 ]
Mysler, Eduardo [4 ]
Kinch, Cassandra [5 ]
Gruben, David [6 ]
Germino, Rebecca [6 ]
Connell, Carol [6 ]
Eder, Lihi [7 ]
机构：
[1] Univ Alberta, Div Rheumatol, Edmonton, AB, Canada
[2] Stanford Univ, Div Immunol Rheumatol, Palo Alto, CA 94304 USA
[3] Univ Munich, Div Rheumatol & Clin Immunol, Dept Internal Med 4, Munich, Germany
[4] Org Med Invest, Buenos Aires, DF, Argentina
[5] Pfizer Canada ULC, Kirkland, WA USA
[6] Pfizer Inc, Groton, CT 06340 USA
[7] Univ Toronto, Coll Res Inst, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2021年 / 48卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
68
引用
收藏
页码：1145 / 1145
页数：1
相关论文
共 50 条
  • [1] SEX DIFFERENCES IN THE EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS: A POST HOC ANALYSIS OF PHASE 3 AND LONG-TERM EXTENSION TRIALS
    Jones, H. N.
    Strand, V.
    Schulze-Koops, H.
    Mysler, E.
    Kinch, C.
    Gruben, D. C.
    Germino, R.
    Connell, C. A.
    Eder, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 565 - 566
  • [2] Sex Differences in the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis Patients: A Post Hoc Analysis of Phase 3 and Long-Term Extension Trials
    Jones, Niall
    Strand, Vibeke
    Schulze-Koops, Hendrik
    Mysler, Eduardo
    Kinch, Cassandra D.
    Gruben, David
    Germino, Rebecca
    Connell, Carol A.
    Eder, Lihi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
    Eder, Lihi
    Gladman, Dafna D.
    Mease, Philip
    Pollock, Remy A.
    Luna, Rayana
    Aydin, Sibel Z.
    Ogdie, Alexis
    Polachek, Ari
    Gruben, David
    Cadatal, Mary Jane
    Kinch, Cassandra
    Strand, Vibeke
    [J]. RMD OPEN, 2023, 9 (01):
  • [4] Tofacitinib in the treatment of Indian patients with rheumatoid arthritis: A post hoc analysis of efficacy and safety in Phase 3 and long-term extension studies over 7 years
    Chopra, Arvind
    Shobha, Vineeta
    Chandrashekara, Srikantiah
    Veeravalli, Sarath C. M.
    Sharma, Reena
    Rao, Uppuluri R.
    Pandya, Sapan
    Wagh, Shrikant
    Kadel, Jugal K.
    Thorat, Amit, V
    Adhav, Charles
    Estrella, Paul Santos
    Yu, Wei
    Kwok, Kenneth
    Wouters, Ann
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 882 - 897
  • [5] Evaluation of Sex Differences in the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
    Eder, Lihi
    Gladman, Dafna
    Aydin, Sibel Zehra
    Ogdie, Alexis
    Shi, Harry
    Landry, Pierre-Alexandre
    Luna, Rayana
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Evaluation of Sex Differences in the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
    Eder, Lihi
    Gladman, Dafna
    Aydin, Sibel
    Ogdie, Alexis
    Shi, Harry
    Landry, Pierre-Alexandre
    Luna, Rayana
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1043 - 1044
  • [7] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    Tesser, John
    Gul, Ahmet
    Olech, Ewa
    Oelke, Kurt
    Lukic, Tatjana
    Kwok, Kenneth
    Ebrahim, Abbas
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [8] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    John Tesser
    Ahmet Gül
    Ewa Olech
    Kurt Oelke
    Tatjana Lukic
    Kenneth Kwok
    Abbas Ebrahim
    [J]. Arthritis Research & Therapy, 25
  • [9] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Mueller, Ruediger B.
    Schulze-Koops, Hendrik
    Furst, Daniel E.
    Cohen, Stanley B.
    Kwok, Kenneth
    Wang, Lisy
    Killeen, Tim
    von Kempis, Johannes
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1045 - 1055
  • [10] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Ruediger B. Mueller
    Hendrik Schulze-Koops
    Daniel E. Furst
    Stanley B.  Cohen
    Kenneth Kwok
    Lisy Wang
    Tim Killeen
    Johannes von Kempis
    [J]. Clinical Rheumatology, 2022, 41 : 1045 - 1055
12345